Welcome to
Together is a new resource for anyone affected by pediatric cancer - patients and their parents, family members, and friends.
Learn MoreAntiretroviral
Odefsey® is a tablet that contains 3 medicines used to treat infection caused by the human immunodeficiency virus (HIV). The 3 medicines are called emtricitabine (Emtriva®), rilpivirine (Edurant®) and tenofovir alafenamide. Emtricitabine and tenofovir alafenamide belong to a group called nucleoside reverse transcriptase inhibitors (NRTIs), and rilpiverine belongs to a group called non-nucleoside reverse transcriptase inhibitors (NNRTIs). Odefsey can slow down how soon you will see symptoms of HIV or slow the damage caused by HIV, but it cannot cure HIV infection. Odefsey tablets contain 200 mg of emtricitabine, 25 mg of tenofovir alafenamide, and 25 mg of rilpivirine.
Symptoms of an allergic reaction include: rash, hives, itching, chills, fever, headache, muscle ache, shortness of breath, coughing, tightness in the throat, swelling of the face or neck.
Not all patients who take Odefsey® will experience these side effects. Common side effects are bolded, but there may be others. Please report all suspected side effects to your doctor or pharmacist.
Find more information on side effects.
During the first few weeks of therapy, some people taking Odefsey develop a skin rash and 2 or more of the following symptoms:
If you develop a rash during the first few weeks of therapy and you have 2 or more of these symptoms, stop taking Odefsey right away and call your St. Jude or nurse. You should not take Odefsey again unless the doctor tells you to do so.
Be sure to discuss all questions and instructions with your doctor or pharmacist.